SATURDAY, OCTOBER 1, 2016

National Institutes of Health

9000 Rockville Pike
Bethesda, MD - 20892

National Institutes of Health News

Maryland researchers produce experimental malaria vaccine

University of Maryland School of Medicine researchers have conducted a new study and have produced an experimental vaccine that can protect adults from malaria for more than a year. Read More »

Study suggests modified cholesterol can inhibit growth of drug-resistant tuberculosis

Researchers from the University of Queensland and University of California San Francisco have found that modified cholesterol can inhibit the growth of the bacterium that causes tuberculosis, a disease that claims a life every 21 seconds. Read More »

NIH organizations issue report on Ebola patient's care

A new report from various organizations under the National Institutes of Health details the clinical course of a 34-year-old American with Ebola virus disease who received intensive supportive care through a clinical trial at the NIH Special Clinical Studies Unit. Read More »

NIH commemorates World Tuberculosis Day

The National Institute of Allergy and Infectious Diseases, a branch of the National Institutes of Health, recently released a statement verifying the organization’s commitment to researching, preventing and treating tuberculosis. Read More »

Blood test predicts chances of TB development

A new study from the South African Tuberculosis Vaccine Initiative at the University of Cape Town suggests that a simple blood test can predict a person’s chances of developing tuberculosis. Read More »

Memory B cells of HIV patients show affinity maturation defects

People with HIV infections experience a wide range of abnormalities in their immune systems, and one of the most recently discovered abnormalities includes affinity maturation defects within the memory B cells. Read More »

All study subjects protected with experimental dengue vaccine

All of the subjects who participated in a clinical trial for an experimental dengue virus vaccine showed vastly different results, as the 21 vaccine recipients did not develop the dengue infection, but the 20 placebo recipients did contract the infection. Read More »

Dengue-fever test vaccine shows promise in early clinical trials

A team of scientists at the University of Vermont (UVM) Vaccine Testing Center has been working to develop an efficient, single-dose vaccine designed to protect people from the four strains of dengue fever, and the team said this week that clinical trials on a test vaccine have been promising so far. Read More »

New regimen reduces drug-resistant malaria severity during pregnancy

A recent study funded by the National Institutes of Health and conducted in Uganda found that a new treatment regimen involving two drugs may be able to reduce the severity of drug-resistant malaria during pregnancy. Read More »

NIAID's HOPE study looks at dapivirine vaginal rings to prevent HIV

Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health (NIH), will proceed with the HIV Open-label Prevention Extension (HOPE) Phase 3B trial to study the use of a dapivirine vaginal ring to prevent HIV in women.  Read More »

Genetic clues from Black Death may help scientists fight HIV and hepatitis C

A recent study from the University of Cincinnati suggests that genetic clues from the Black Death may be helpful in developing antiretroviral drug therapy treatments for people with HIV and hepatitis C infections. Read More »

Experimental antibody shields monkeys from Ebola

Researchers from the National Institute of Allergy and Infectious Diseases, a branch of the National Institutes of Health, recently developed an antibody that protects monkeys from developing Ebola infections. Read More »

Vaginal ring with antiretroviral drug offers partial HIV protection

The National Institutes of Health recently conducted studies that show an antiretroviral drug within a vaginal ring may be the strongest protector for women against HIV infections. Read More »

Study shows CMV vaccine is effective against Ebola

A recent study shows the cytomegalovirus (CMV) vaccine may be effective in protecting people from contracting the Ebola virus, which caused a recent outbreak in West Africa. Read More »

Profectus BioSciences launches phase 1 clinical trial for Ebola vaccine

Profectus BioSciences Inc., a clinical-stage vaccine company that creates vaccines to prevent and treat infectious diseases and cancers, recently began its Phase 1 clinical trial to evaluate the immunogenicity and safety of the company’s Ebola virus. Read More »

Global coordinator pushes for stronger, more focused anti-HIV efforts

Dr. Deborah Birx, the U.S. Global AIDS Coordinator who monitors the President’s Emergency Plan for AIDS Relief (PEPFAR), recently called for stronger efforts against HIV infections around the world as she presented at the National Institutes of Health (NIH). Read More »

NIAID highlights accomplishments from 2015

The National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health, recently released a slideshow that emphasizes the notable scientific progress that NIAID researchers have accomplished for 2015. Read More »

Immune responses may inhibit antibody-based treatments for HIV

Researchers from the Medical University of South Carolina recently conducted studies to determine whether immune responses inhibit the results of broadly neutralizing antibody treatments that may help people with HIV infections. Read More »

NIH outlines strategic plan, initiatives for 2016

NIH has published its strategic plan and initiatives for 2016 as a result of the solicitation of NIH advisory councils. Read More »

Illinois study shows emerging, bacteria-targeting uses from medications

A new study led by Illinois chemistry professor Eric Oldfield has found new uses for medications brought to market to treat cancer, fertility issues and particular types of infections.  Read More »